Close
The page header's logo
Help
Login
Staff Login
Register
FR
0
Selected 
Invert selection
Deselect all
Deselect all
 Add to Cart
 Click here to refresh results
 Click here to refresh results
Go to Login page
 Hide details
doctype icon
Conceptually similar
Merck announces Molnupiravir manufacturing in Canada for COVID-19
play button
CP143754121 | Merck announces Molnupiravir manufacturing in Canada for COVID-19 
Newsroom Ready: Ontario residents react to mask mandates being lifted in most public spaces
play button
CP152985172 | Newsroom Ready: Ontario residents react to mask mandates being lifted in most public spaces 
Newsroom Ready: Canada's $850M promise for international COVID-19 fight 'only a beginning'
play button
CP17178071 | Newsroom Ready: Canada's $850M promise for international COVID-19 fight 'only a beginning' 
Newsroom Ready: Canada buys options for fifth potential COVID-19 vaccine
play button
CP19569821 | Newsroom Ready: Canada buys options for fifth potential COVID-19 vaccine 
Newsroom Ready: Health Canada approves COVID-19 vaccine
play button
CP112898221 | Newsroom Ready: Health Canada approves COVID-19 vaccine 
Newsroom Ready: Health Canada aims to speed COVID-19 vaccine approvals: Tam
play button
CP18981855 | Newsroom Ready: Health Canada aims to speed COVID-19 vaccine approvals: Tam 
Newsroom Ready: Child COVID-19 vaccinations ramp up in Ontario
play button
CP142522771 | Newsroom Ready: Child COVID-19 vaccinations ramp up in Ontario 
Newsroom Ready: As Russia moves ahead with COVID-19 vaccine, Tam expresses confidence in Health Canada's process
play button
CP18576697 | Newsroom Ready: As Russia moves ahead with COVID-19 vaccine, Tam expresses confidence in Health Canada's process 
Newsroom Ready: Plane carrying COVID-19 vaccines for kids touches down in Canada
play button
CP142140621 | Newsroom Ready: Plane carrying COVID-19 vaccines for kids touches down in Canada 
Newsroom Ready: National plans for COVID-19 vaccine distribution in the works: Hajdu
play button
CP111820471 | Newsroom Ready: National plans for COVID-19 vaccine distribution in the works: Hajdu 
Action button
Placeline/People
City Vaughan
Country Canada

Newsroom Ready: Merck announces Molnupiravir manufacturing in Canada for COVID-19

Merck has announced a partnership with Thermo Fisher Scientific to manufacture Molnupiravir, an oral antiviral medicine for the treatment of COVID-19, in Whitby, Ont. The companies will manufacture Molnupiravir for distribution in Canada and the U.K., as well as markets in Europe, Asia and Latin America, pending local market approvals. 
Actions
 Add to collection
 Add to cart
Information
Source name: 
The Canadian Press
Unique identifier: CP143756471 
Legacy Identifier: r_COVID-Treatment20211206T1330 
Type: Video 
Duration: 2m38s 
Dimensions: 1920px × 1080px     195.98 MB 
Usage rights: FOR ONE TIME USE ONLY. NO STORAGE FOR FUTURE USE. 
Create Date: 12/6/2021 1:30:00 PM 
Display aspect ratio: 16:9 
Tags
Coronavirus
COVID-19
Francois-Phillipe Champagne
health
Marwan Akar
Merck
Ontario
oral antiviral medicine
Ryan Turnbull
safety
toronto
treatment
vaccine